Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -141,437 | -108,825 | -56,849 | -176,145 | -126,710 |
| Depreciation Amortization | 3,039 | 2,019 | 1,328 | 1,392 | 963 |
| Accounts receivable | 384 | 6,287 | 3,855 | -13,651 | -4,355 |
| Accounts payable and accrued liabilities | -3,072 | -1,911 | 9,533 | -3,563 | 1,390 |
| Other Working Capital | -816 | 5,092 | 13,815 | -14,032 | -7,956 |
| Other Operating Activity | 12,788 | 2,273 | -10,793 | 40,281 | 21,768 |
| Operating Cash Flow | $-129,114 | $-95,065 | $-39,111 | $-165,718 | $-114,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -39 | -26 | -21 | -2,450 | -2,089 |
| Purchase Sale Intangibles | -1,065 | -816 | -422 | -21,442 | -1,069 |
| Other Investing Activity | -1,065 | -816 | -422 | -21,442 | -1,089 |
| Investing Cash Flow | $-1,104 | $-842 | $-443 | $-23,892 | $-3,178 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 50,000 | 50,000 | 50,000 | 200,000 | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 200,000 |
| Debt Repayment | N/A | N/A | N/A | N/A | -81,661 |
| Common Stock Issued | 272 | 166 | 72 | 77,140 | 109 |
| Other Financing Activity | -1,250 | -1,250 | -1,250 | -88,313 | -6,652 |
| Financing Cash Flow | $49,022 | $48,916 | $48,822 | $188,827 | $111,796 |
| Beginning Cash Position | 160,830 | 160,830 | 160,830 | 161,613 | 161,613 |
| End Cash Position | 79,634 | 113,839 | 170,098 | 160,830 | 155,330 |
| Net Cash Flow | $-81,196 | $-46,991 | $9,268 | $-783 | $-6,283 |
| Free Cash Flow | |||||
| Operating Cash Flow | -129,114 | -95,065 | -39,111 | -165,718 | -114,900 |
| Capital Expenditure | -39 | -26 | -21 | -2,450 | -2,089 |
| Free Cash Flow | -129,153 | -95,091 | -39,132 | -168,168 | -116,990 |